Results 51 to 60 of about 670 (68)

[Application of <i>flavonoid</i> in disease treatment based on multi-omics technologies]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Zhang W, Han K, Zhao K, Yang C, Jin M, Wang Y, Jiang Z.   +6 more
europepmc   +1 more source

[<i>Ching Shum</i> Pills alleviates non-alcoholic fatty liver disease in mice by ameliorating lipid metabolism disorders]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Luo B, Yi X, Cai Y, Zhang S, Wang P, Li T, Yung KKL, Zhou P.   +7 more
europepmc   +1 more source

[Hypaphorine alleviates Crohn's disease-like colitis in mice by inhibiting intestinal epithelial inflammatory response and protecting intestinal barrier function]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Huang Q, Yang J, Jiang X, Zhang W, Wang Y, Zuo L, Wang L, Wang Y, Zhang X, Song X, Hu J.   +10 more
europepmc   +1 more source

[Biological characteristics of liver zonation and its role in disease and aging]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Gu PY, Xin JX, Yin KL, Zhou CX, Zhang R, Shao SS.   +5 more
europepmc   +1 more source

[Research progress on external cervical resorption]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Chen R, Bian M, Zhao J, Qian L, Shi Y, Wu Z.   +5 more
europepmc   +1 more source

[<i>Morinda officinalis</i> polysaccharide delays osteoarthritis mouse chondrocyte degeneration by modulating the glycolysis-pyroptosis axis <i>via</i> targeting the lncRNA XIST]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Fu C, Chen R, Xu S, You J, Lin Q, Huang Y.   +5 more
europepmc   +1 more source

[<i>Guijianyu</i> alleviates advanced glycation endproducts-induced mouse renal podocyte injury by inhibiting the AGEs-RAGE signaling pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Ma Q, Niu Y, Zuo M, Li X, Fu J, Wang J.
europepmc   +1 more source

[Analysis and comparison of bile acid metabolism characteristics in children and adults with metabolic- associated fatty liver disease]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Yang CH, Mei N, Wang Y, Liu AN, Rong R, Lyu QT, Zheng MH, Ni Y.   +7 more
europepmc   +1 more source

[EVA1A overexpression improves non-alcoholic fatty liver disease in mice by regulating lipid metabolism and promoting lipophagy]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Xu J, Yang D, Zang K, Chu M, Zhao Q, Li Q, Lu S, Chen X, Li N.   +8 more
europepmc   +1 more source